19.09.2016 • NewsArkemaDede Willamsfluorogas

Arkema to Close French R134a Plant

(c) Arkema
(c) Arkema

Citing changes in EU legislation, French chemical producer Arkema has presented to its works council a plan to close the R134a fluorogas plant at its Pierre-Bénite site in France, with effect from the first quarter of 2017.

The site that produces fluorinated products for wide-ranging applications, with a heavy emphasis on R134a, would refocus on other fluorogases, fluorinated blends and derivatives for the stationary air-conditioning, refrigeration and non-emissive uses markets, as well as the manufacture of fluoropolymers and certain catalysts.

Arkema noted that the European R134a market is set to undergo “an inevitable decline” from the beginning of 2017 as an EU directive banning the fluorogas’s use in automotive air conditioning applications – the main outlet for the French producer’s R134a business in Europe – goes into effect.                 

Shuttering production facilities for R134 at Pierre-Bénite would require a reorganization of the site but at the same time improve competitiveness, the company said, adding that the closure would have no effect on the number of jobs, as the 38 employees made redundant would be redeployed.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read